Dr. Amy Krambeck discusses 90-day trial of disposable ureteroscope

The highest cumulative 120-day rates of ED visits and HA were observed in patients who underwent percutaneous nephrolithotomy procedures.

"I think there's a lot of fear that can go into talking about these topics," says Katherine Rotker, MD.

The patient was treated as part of a clinical study of the novel MONARCH platform at UCI Health in California.

"Hopefully, this will be a resource for people who are preparing for birth, or who have recently experienced birth," says Linda Brubaker, MD, MS.

As the year comes to a close, we revisit some of this year’s top content on urologic stones.

Thomas Chi, MD, discusses 2022 milestones in stone disease and looks ahead to what might be on the horizon for the field in the coming year.